Phoenix Life Sciences International Limited. Stock-Based Compensation
Phoenix Life Sciences International Limited. reported Stock-Based Compensation of $131.25 thousand for the 6-month period ending 2018-08-31, per its 10-Q filed 2019-04-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2019-04-25
- Phoenix Life Sciences International Limited. share-based payment arrangement, noncash expense for the quarter ending 2018-08-31 was $0.00.
- Phoenix Life Sciences International Limited. share-based payment arrangement, noncash expense for the quarter ending 2018-05-31 was $131.25K.
- Phoenix Life Sciences International Limited. share-based payment arrangement, noncash expense for the quarter ending 2015-02-28 was $247.66K.
- Phoenix Life Sciences International Limited. share-based payment arrangement, noncash expense for fiscal 2015 was $360.58K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2018-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-25 | $131.25K 10-Q · filed 2019-04-25 | ||
| 2018-05-31 | $131.25K 10-Q · filed 2019-04-25 | |||
| 2015-02-28 | $247.66K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $360.58K 10-K · filed 2019-03-13 | ||
| 2014-11-30 | $112.91K 10-Q · filed 2019-04-16 |